Dr. Divya Haryani
Media links:
New High Tech Therapy to Treat Skin Cancer without Scarring
Derm Diaries: ‘I’m a Dermatologist With Acne And Hyperpigmentation—Here’s How I Treat It’
Dermatology duo: ‘Saving people’s lives is ultimate goal’
The Best Drugstore Serums Dermatologists Actually Love
These 5 Skincare Trends Are the Wave of the Future, and You'll See 'Em Everywhere in 2020
Board Certified Dermatologist
Board Certified Mohs Micrographic Surgeon and Cutaneous Oncologist
Skin Cancer Specialist
Dr. Divya Haryani, M.D. is a leading double board-certified dermatologist and recognized key opinion leader in both cutaneous oncology and mohs micrographic surgery & reconstruction. Her background is uniquely cross-pollinated with integrated training in dermatologic surgery, facial reconstructive surgery, and cutaneous oncology at the prestigious University of South Florida in Tampa and world renowned Moffitt Cancer Center, Melanoma & Cutaneous Oncology department (widely acknowledged as one of the top cancer centers in the United States, especially for its pioneering work in melanoma research and treatment). Dr. Haryani's primary focus is recognizing and treating both the most common and complex forms of basal cell carcinoma, squamous cell carcinoma, and melanoma. Her training was both rigorous and comprehensive, encompassing a variety of therapies including superficial radiation therapy, mohs surgery and immunotherapy for non melanoma skin cancer & melanoma at the cancer center.
A prolific researcher and innovator, Dr. Divya Haryani was involved in several clinical trials at Northwestern Memorial Hospital (Chicago, IL) that have revolutionized the field of dermatology. She has published original research relating to mohs surgery, cosmetic dermatology and scar treatments (see citations below). She has also authored several chapters in major medical textbooks.
Dr. Haryani is a trusted and popular source for the local and national media; her credentials and her ability to communicate clearly and effectively via television, online and in-print has made her a sought after opinion leader. She has been featured on several outlets, including ABC news, Buzzfeed and Yahoo to name a few. She is also a frequent lecturer at academic meetings.
At Iconic Dermatology, Dr. Divya Haryani collaborates with her team and other leading oncologists locally and nationally to create individualized treatment plans for each and every patient, refining them as necessary to ensure the best possible outcome and quality of life for those we serve. As a practice, we offer the latest advances in skin cancer treatment, such as cryotherapy and immunotherapy, as well as traditional procedures, such as mohs micrographic surgery and electrodessication. Targeted superficial radiation therapy, immunotherapy and chemotherapy are evolving as mainstays in treatment protocols and are offered at our practice and partnering practices locally. In the Treasure Coast, Dr. Divya’s approach is well known and has led to exceptional outcomes for our community.
When asked about her philosophy of patient care, she keeps it simple, “Treat every patient like a family member.” Outside of the office, Dr. Haryani enjoys spending time with her own family (husband, daughter and son), reading, and listening to podcasts. She also actively participates in philanthropic endeavors and volunteer work, supporting her native community of Vero Beach.
Publications:
Pubmed: Divya (Sadhwani) Haryani, MD
Assessing the effectiveness of knowledge-based interventions in increasing skin cancer awareness, knowledge, and protective behaviors in skin of color populations.
Kailas A, Botwin AL, Pritchett EN, Jackson-Richards D, Lewis S, Sadhwani D, Desai SR, Taylor SC.
Cutis. 2017 Oct;100(4):235-240.
An office-based procedure for hyphema treatment.
MomPremier M, Sadhwani D, Shaikh S.
Case Rep Ophthalmol Med. 2015;2015:321076. doi: 10.1155/2015/321076. Epub 2015 Mar 18.
En coup de sabre morphea treated with hyaluronic acid filler. Report of a case and review of the literature.
Thareja SK, Sadhwani D, Alan Fenske N.
Int J Dermatol. 2015 Jul;54(7):823-6. doi: 10.1111/ijd.12108. Epub 2013 Oct 29.
Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center.
Zeb L, Mhaskar R, Lewis S, Patel NS, Sadhwani D, Patel N, Ekhlassi E, Lu Y, Seminario-Vidal L.
Dermatol Ther. 2021 Mar;34(2):e14826. doi: 10.1111/dth.14826. Epub 2021 Feb 12.
Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing.
Hattori Y, Falgout L, Lee W, Jung SY, Poon E, Lee JW, Na I, Geisler A, Sadhwani D, Zhang Y, Su Y, Wang X, Liu Z, Xia J, Cheng H, Webb RC, Bonifas AP, Won P, Jeong JW, Jang KI, Song YM, Nardone B, Nodzenski M, Fan JA, Huang Y, West DP, Paller AS, Alam M, Yeo WH, Rogers JA.
Adv Healthc Mater. 2014 Oct;3(10):1597-607. doi: 10.1002/adhm.201400073. Epub 2014 Mar 26.
Utility of a High-Resolution Superficial Diagnostic Ultrasound System for Assessing Skin Thickness: A Cross-Sectional Study.
Iyengar S, Makin IR, Sadhwani D, Moon E, Yanes AF, Geisler A, Silapunt S, Servaes S, Weil A, Poon E, Alam M.
Dermatol Surg. 2018 Jun;44(6):855-864. doi: 10.1097/DSS.0000000000001445.
Subcutaneous infiltration of carbon dioxide (carboxytherapy) for abdominal fat reduction: A randomized clinical trial.
Alam M, Sadhwani D, Geisler A, Aslam I, Makin IRS, Schlessinger DI, Disphanurat W, Pongprutthipan M, Voravutinon N, Weil A, Chen BR, West DP, Veledar E, Poon E.
J Am Acad Dermatol. 2018 Aug;79(2):320-326. doi: 10.1016/j.jaad.2018.04.038. Epub 2018 Apr 24.
Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.
Thareja S, Zager JS, Sadhwani D, Thareja S, Chen R, Marzban S, Jukic DM, Glass LF, Messina J.
Am J Dermatopathol. 2014 Jan;36(1):64-7. doi: 10.1097/DAD.0b013e31829433b6.
Fertility Preservation Preferences and Perspectives Among Adult Male Survivors of Pediatric Cancer and Their Parents.
Stein DM, Victorson DE, Choy JT, Waimey KE, Pearman TP, Smith K, Dreyfuss J, Kinahan KE, Sadhwani D, Woodruff TK, Brannigan RE.
J Adolesc Young Adult Oncol. 2014 Jun 1;3(2):75-82. doi: 10.1089/jayao.2014.0007.
A Comparative Split-Face Study Using Different Mild Purpuric and Subpurpuric Fluence Level of 595-nm Pulsed-Dye Laser for Treatment of Moderate to Severe Acne Vulgaris.
Voravutinon N, Rojanamatin J, Sadhwani D, Iyengar S, Alam M.
Dermatol Surg. 2016 Mar;42(3):403-9. doi: 10.1097/DSS.0000000000000658.
Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial.
Alam M, Geisler A, Sadhwani D, Goyal A, Poon E, Nodzenski M, Schaeffer MR, Tung R, Minkis K.
JAMA Dermatol. 2015 Nov;151(11):1194-9. doi: 10.1001/jamadermatol.2015.2232.
Board Certified Dermatologist
Board Certified Mohs Micrographic Surgeon and Cutaneous Oncologist
Skin Cancer Specialist
Dr. Divya Haryani, M.D. is a leading double board-certified dermatologist and recognized key opinion leader in both cutaneous oncology and mohs micrographic surgery & reconstruction. Her background is uniquely cross-pollinated with integrated training in dermatologic surgery, facial reconstructive surgery, and cutaneous oncology at the prestigious University of South Florida in Tampa and world renowned Moffitt Cancer Center, Melanoma & Cutaneous Oncology department (widely acknowledged as one of the top cancer centers in the United States, especially for its pioneering work in melanoma research and treatment). Dr. Haryani's primary focus is recognizing and treating both the most common and complex forms of basal cell carcinoma, squamous cell carcinoma, and melanoma. Her training was both rigorous and comprehensive, encompassing a variety of therapies including superficial radiation therapy, mohs surgery and immunotherapy for non melanoma skin cancer & melanoma at the cancer center.
A prolific researcher and innovator, Dr. Divya Haryani was involved in several clinical trials at Northwestern Memorial Hospital (Chicago, IL) that have revolutionized the field of dermatology. She has published original research relating to mohs surgery, cosmetic dermatology and scar treatments (see citations below). She has also authored several chapters in major medical textbooks.
Dr. Haryani is a trusted and popular source for the local and national media; her credentials and her ability to communicate clearly and effectively via television, online and in-print has made her a sought after opinion leader. She has been featured on several outlets, including ABC news, Buzzfeed and Yahoo to name a few. She is also a frequent lecturer at academic meetings.
At Iconic Dermatology, Dr. Divya Haryani collaborates with her team and other leading oncologists locally and nationally to create individualized treatment plans for each and every patient, refining them as necessary to ensure the best possible outcome and quality of life for those we serve. As a practice, we offer the latest advances in skin cancer treatment, such as cryotherapy and immunotherapy, as well as traditional procedures, such as mohs micrographic surgery and electrodessication. Targeted superficial radiation therapy, immunotherapy and chemotherapy are evolving as mainstays in treatment protocols and are offered at our practice and partnering practices locally. In the Treasure Coast, Dr. Divya’s approach is well known and has led to exceptional outcomes for our community.
When asked about her philosophy of patient care, she keeps it simple, “Treat every patient like a family member.” Outside of the office, Dr. Haryani enjoys spending time with her own family (husband, daughter and son), reading, and listening to podcasts. She also actively participates in philanthropic endeavors and volunteer work, supporting her native community of Vero Beach.
Media links:
Bay News Media Interview 1:
Bay News Clip 1Bay News Media Interview 2:
Bay News Clip 2Acne Products That Work:
https://mynews13.com/fl/orlando/news/2018/2/13/consumer_wise_acne_pNew High Tech Therapy to Treat Skin Cancer without Scarring:
https://veronews.com/2023/04/06/new-high-tech-therapy-treats-skin-cancer-without-scarring/Like Mother Like Daughter:
https://verobeachmagazine.com/features/like-mother-like-daughter-2/Derm Diaries: ‘I’m a Dermatologist With Acne And Hyperpigmentation—Here’s How I Treat It’:
https://www.womenshealthmag.com/beauty/a35537936/dermatologist-acne-and-inflammatory-dark-spots/Dermatology duo: ‘Saving people’s lives is ultimate goal’:
https://veronews.com/2021/04/08/dermatology-duo-saving-peoples-lives-is-ultimate-goal/The Best Drugstore Serums Dermatologists Actually Love:
https://www.newbeauty.com/best-derm-recommended-drugstore-serums/4These 5 Skincare Trends Are the Wave of the Future, and You'll See 'Em Everywhere in 2020:
https://www.popsugar.com/beauty/biggest-skincare-trends-2020-according-to-experts-47003162 Publications:
Pubmed: Divya (Sadhwani) Haryani, MD
Assessing the effectiveness of knowledge-based interventions in increasing skin cancer awareness, knowledge, and protective behaviors in skin of color populations.
Kailas A, Botwin AL, Pritchett EN, Jackson-Richards D, Lewis S, Sadhwani D, Desai SR, Taylor SC.
Cutis. 2017 Oct;100(4):235-240.
An office-based procedure for hyphema treatment.
MomPremier M, Sadhwani D, Shaikh S.
Case Rep Ophthalmol Med. 2015;2015:321076. doi: 10.1155/2015/321076. Epub 2015 Mar 18.
En coup de sabre morphea treated with hyaluronic acid filler. Report of a case and review of the literature.
Thareja SK, Sadhwani D, Alan Fenske N.
Int J Dermatol. 2015 Jul;54(7):823-6. doi: 10.1111/ijd.12108. Epub 2013 Oct 29.
Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center.
Zeb L, Mhaskar R, Lewis S, Patel NS, Sadhwani D, Patel N, Ekhlassi E, Lu Y, Seminario-Vidal L.
Dermatol Ther. 2021 Mar;34(2):e14826. doi: 10.1111/dth.14826. Epub 2021 Feb 12.
Multifunctional skin-like electronics for quantitative, clinical monitoring of cutaneous wound healing.
Hattori Y, Falgout L, Lee W, Jung SY, Poon E, Lee JW, Na I, Geisler A, Sadhwani D, Zhang Y, Su Y, Wang X, Liu Z, Xia J, Cheng H, Webb RC, Bonifas AP, Won P, Jeong JW, Jang KI, Song YM, Nardone B, Nodzenski M, Fan JA, Huang Y, West DP, Paller AS, Alam M, Yeo WH, Rogers JA.
Adv Healthc Mater. 2014 Oct;3(10):1597-607. doi: 10.1002/adhm.201400073. Epub 2014 Mar 26.
Utility of a High-Resolution Superficial Diagnostic Ultrasound System for Assessing Skin Thickness: A Cross-Sectional Study.
Iyengar S, Makin IR, Sadhwani D, Moon E, Yanes AF, Geisler A, Silapunt S, Servaes S, Weil A, Poon E, Alam M.
Dermatol Surg. 2018 Jun;44(6):855-864. doi: 10.1097/DSS.0000000000001445.
Subcutaneous infiltration of carbon dioxide (carboxytherapy) for abdominal fat reduction: A randomized clinical trial.
Alam M, Sadhwani D, Geisler A, Aslam I, Makin IRS, Schlessinger DI, Disphanurat W, Pongprutthipan M, Voravutinon N, Weil A, Chen BR, West DP, Veledar E, Poon E.
J Am Acad Dermatol. 2018 Aug;79(2):320-326. doi: 10.1016/j.jaad.2018.04.038. Epub 2018 Apr 24.
Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.
Thareja S, Zager JS, Sadhwani D, Thareja S, Chen R, Marzban S, Jukic DM, Glass LF, Messina J.
Am J Dermatopathol. 2014 Jan;36(1):64-7. doi: 10.1097/DAD.0b013e31829433b6.
Fertility Preservation Preferences and Perspectives Among Adult Male Survivors of Pediatric Cancer and Their Parents.
Stein DM, Victorson DE, Choy JT, Waimey KE, Pearman TP, Smith K, Dreyfuss J, Kinahan KE, Sadhwani D, Woodruff TK, Brannigan RE.
J Adolesc Young Adult Oncol. 2014 Jun 1;3(2):75-82. doi: 10.1089/jayao.2014.0007.
A Comparative Split-Face Study Using Different Mild Purpuric and Subpurpuric Fluence Level of 595-nm Pulsed-Dye Laser for Treatment of Moderate to Severe Acne Vulgaris.
Voravutinon N, Rojanamatin J, Sadhwani D, Iyengar S, Alam M.
Dermatol Surg. 2016 Mar;42(3):403-9. doi: 10.1097/DSS.0000000000000658.
Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin Type A Injections: A Randomized Clinical Trial.
Alam M, Geisler A, Sadhwani D, Goyal A, Poon E, Nodzenski M, Schaeffer MR, Tung R, Minkis K.
JAMA Dermatol. 2015 Nov;151(11):1194-9. doi: 10.1001/jamadermatol.2015.2232.
